community acquired pneumonie (CAP) - S. aureus (non-MRSA)
Advices
| Priority | Medication | Remarks |
|---|---|---|
|
Priority: 1st choice |
Medication: flucloxacilline po 500mg 4dd 7 to 14 days |
Remarks:
Bij niet-klinische patiënten kan orale therapie worden overwogen |
|
Priority: 1st choice |
Medication: flucloxacilline iv 6g continuous per 24 hours 7 to 14 days |
Remarks:
Bij opname en/of ernstige presentatie: flucloxacilline oplaaddosering 1g iv gevolgd door continu infuus 6g/24u iv OF flucloxacilline 6dd 1g iv Overweeg orale switch na klinische verbetering EN afwezigheid bacteriëmie |
| Priority | Medication | Remarks |
|---|---|---|
|
Priority: 1st choice |
Medication: cefazoline iv 4g continuous per 24 hours 7 to 14 days |
Remarks:
Cefazoline oplaaddosering 1g iv gevolgd door continu infuus 4g/24u iv OF cefazoline 4dd 1g iv |
| Priority | Medication | Remarks |
|---|---|---|
|
Priority: 1st choice |
Medication: vancomycine iv 7 to 14 days |
Remarks:
Vancomycine dosering en TDM in overleg met ziekenhuisapotheker |
Sources
Antimicrobial resources
The following antimicrobial agents have been used in these recommendations:
- flucloxacilline
- cefazoline
- vancomycine
External antimicrobial resources
Menu position
Metadata
Swab vid: G-501763.1
Updated: 09/01/2023 - 08:33
Status: Published